Porth R, Deyhim T, Zullow S, Rabinowitz LG, et al. Proactive Therapeutic Drug Monitoring Is Associated With Increased Drug Persistence in Patients With Inflammatory Bowel Disease Treated With Intravenous Vedolizumab. Inflamm Bowel Dis 2024 Jul 2:izae140. doi: 10.1093.
PMID: 38953651